| Name | Title | Contact Details |
|---|---|---|
Alicia Hawkins |
Vice President Legal | Profile |
Lauren Amlin |
Senior Director, Compliance | Profile |
Lizabeth Muniz |
Managing Director, Senior Counsel | Profile |
Jordan Flynn |
Vice President, Chief Compliance Officer | Profile |
Hart Enterprises Inc is a Sparta, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Prudent Choice is a Irvine, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Prisim Medical Products (was Freeway Healthcare) is a Elkin, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Valeritas is committed to developing and commercializing innovative treatment solutions that contribute to clinical and humanistic outcomes for patients, with an initial focus on the treatment of Type 2 diabetes. Valeritas` portfolio is headlined by the V-Go® disposable insulin delivery device, which is being commercialized and reimbursed in a specialty pharmaceutical model and is distributed through retail pharmacy.
Contego Medical, founded in 2005, has developed a family of novel emboli protection devices. The main feature of each device is that the treatment portion (i.e., balloon or stent) is on the same catheter as the embolic protection device, thus coupling the two together. This device can act as an angioplasty balloon with an integrated emboli protection device. If a stent is mounted on the balloon, it can serve as a stent with an integrated emboli protection device. We know that embolization occurs with all angioplasty and stenting procedures. It is usually hard to predict which ones will result in clinical sequalae. Despite knowing that embolization is ubiquitous, embolic protection devices are not used in all procedures as they add complexity, time, and cost. Dedicated devices do not exist for renal intervention, although the majority of physicians say they would use one if it existed. Contego Medical’s family of embolic protection devices represent a paradigm shift in the treatment of cardiovascular disease.